Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Werewolf Therapeutics, Inc. - Common Stock (NQ:HOWL)

0.9650 -0.0150 (-1.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 863,560
Open 0.9749
Bid (Size) 0.9600 (96,400)
Ask (Size) 0.9606 (200)
Prev. Close 0.9800
Today's Range 0.9501 - 0.9895
52wk Range 0.2700 - 2.380
Shares Outstanding 27,567,728
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
+49.7%
+49.7%
1 Month
+152.6%
+152.6%
3 Month
+157.7%
+157.7%
6 Month
+30.4%
+30.4%
1 Year
-27.4%
-27.4%

More News

Read More
News headline image
Halper Sadeh LLC is Investigating Whether HOWL, BZH, MKTX, CBZ are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Werewolf Therapeutics (NASDAQ:HOWL) Meets Q1 Estimates, Clears Debt, and Advances Strategic Review ↗
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
HOWL Stock Alert: Halper Sadeh LLC is Investigating Whether Werewolf Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
Friday's session: top gainers and losers ↗
Via Chartmill
Friday's session: most active stocks ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
From Ambros Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives ↗
Via Stocktwits
Topics Workforce
News headline image
Top movers in Thursday's session ↗
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Thursday's session. ↗
Via Chartmill

Frequently Asked Questions

Is Werewolf Therapeutics, Inc. - Common Stock publicly traded?
Yes, Werewolf Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Werewolf Therapeutics, Inc. - Common Stock trade on?
Werewolf Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Werewolf Therapeutics, Inc. - Common Stock?
The ticker symbol for Werewolf Therapeutics, Inc. - Common Stock is HOWL on the Nasdaq Stock Market
What is the current price of Werewolf Therapeutics, Inc. - Common Stock?
The current price of Werewolf Therapeutics, Inc. - Common Stock is 0.9650
When was Werewolf Therapeutics, Inc. - Common Stock last traded?
The last trade of Werewolf Therapeutics, Inc. - Common Stock was at 09/09/26 04:00 PM ET
What is the market capitalization of Werewolf Therapeutics, Inc. - Common Stock?
The market capitalization of Werewolf Therapeutics, Inc. - Common Stock is 26.60M
How many shares of Werewolf Therapeutics, Inc. - Common Stock are outstanding?
Werewolf Therapeutics, Inc. - Common Stock has 27M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.